medigraphic.com
ISSN 1029-3035 (Electronic)

2013, Number S2

<< Back Next >>

Mediciego 2013; 19 (S2)

Probiotics and human health

Delgado FR

Language: Spanish
References: 43
Page:
PDF size: 252.31 Kb.


ABSTRACT

The use of probiotic microorganisms is not new, since long time ago, man has been using them empirically, have only recently been studied and reveal the mechanisms by which they exert beneficial effects on human health and alleviate various pathologies. This work is an updated overview of the probiotics knowledge, their characteristics, their mode of action, and the beneficial effect they have on human health. Also shows the important role in the functioning of the digestive system and different methods by which exert beneficial effects: competition with harmful bacteria shift its binding site and inhibiting epithelial growth and death by producing antibacterial compounds or lowering the pH, improving the intestinal barrier function, production of important nutrients for intestinal function as well as immunomodulation. It reflects on the use of probiotics as an alternative in the treatment of various diseases that affect human health, always considering that the proper use of them, the family used and the dose will be vital factors in the success.


REFERENCES

  1. Health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria [Internet]. Córdoba: Food and Agriculture Organization of the United Nations and the World Health Organization; c. 2001-2008 [actualizada 2 Jul 2008; citado 2 Jul 2008] [aprox. 10 pantallas]. Disponible en: http://www.who.int/foodsafety/publications/fs_management/en/probiotics.pdf

  2. Donovan SM, Schneeman B, Gibson GR, Sanders ME. Establishing and evaluating health claims for probiotics. Adv Nutr. 2012; 3(5):723-5.

  3. Floch MH. Recommendations for probiotic use. J Clin Gastroenterol. 2008; 42(Suppl. 2): S104–S108.

  4. Wallace TC, Guarner F, Madsen K, Cabana MD, Gibson G, Sanders ME, et al. Human gut microbiota and its relationship to health and disease. Nutr Rev. 2011; 69(7):392-403.

  5. Turner JR. Intestinal mucosal barrier function in health and disease. Nat Rev Immunol. 2009; 9: 799–809.

  6. Sonnenburg ED. Specificity of polysaccharide use in intestinal bacteroides species determines diet-induced microbiota alterations. Cell. 2010; 141: 1241–1252.

  7. Ringel Y, Carroll IM. Alterations in the intestinal microbiota and functional bowel symptoms. Gastrointest Endosc Clin N Am. 2009; 19: 141–150.

  8. Hill C. Probiotics and pharmabiotics. Bioeng Bugs. 2010; 1: 79–84.

  9. Morrison DJ, Mackay WG, Edwards CA, Preston T, Dodson B, Weaver LT. Butyrate production from oligofructose fermentation by the human faecal flora: what is the contribution of extracellular acetate and lactate? Br J Nutr. 2006; 96: 570-577.

  10. Corr SC. Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118. Proc Nat Acad Sci. 2007; 104: 7617–7621.

  11. Shiba T, Aiba Y, Ishikawa H, Ushiyama A, Takagi A, Mine T, et al. The suppressive effect of bifidobacteria on Bacteroides vulgatus, a putative pathogenic microbe in inflammatory bowel disease. Microbiol Immunol. 2003; 47:371-378.

  12. Plevy S. The immunology of inflammatory bowel disease. Gastroenterol Clin North Am. 2002; 31(1):77-92.

  13. Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of bifidobacteria fermented milk on ulcerative colitis. J Am Coll Nutr.2003; 22: 56- 63.

  14. Pacheco KC, del Toro GV, Martínez FR, Duran Paramo E. Viability of Lactobacillus delbrueckii under human gastrointestinal conditions simulated in vitro. Am J Agric Biol Sci. 2010; 5:37- 42.

  15. Sanders ME. How do we know when something called “probiotic” is really a probiotic? A guideline for consumers and health care professionals. Funct Food Rev. 2009; 1(1): 3-12.

  16. Stibich M. What are probiotics and should i take them? [Internet]. Washington: Medical Review Board; c. 2001-2013. [actualizada 5 de Ago 2010; citado 29 Sep 2013] [aprox. 2 pantallas]. Disponible en: http://longevity.about.com/od/antiagingsupplements/a/What-Are- Probiotics-And-Should-I-Take-Them.htm

  17. Kekkonen RA, Lummela N, Karjalainen H. Probiotic intervention has strain-specific antiinflammatory effects in healthy adults. World J Gastroenterol. 2008; 14: 2029–36.

  18. Lomax AR, Calder PC. Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Curr Pharm Des. 2009; 15:1428–1518.

  19. Boge T, Remigy M, Vaudaine S. A probiotic fermented dairy drink improves antibody response to influenza vaccination in the elderly in two randomised controlled trials. Vaccine. 2009; 27:5677–84.

  20. French PW, Penny R. Use of probiotic bacteria as an adjuvant for an influenza vaccine. Int J Prebiot Probiot. 2009; 4:175–180.

  21. Leyer GJ, Li S, Mubasher ME. Probiotic effects on cold and influenza-like symptom incidence and duration in children. Pediatrics. 2009; 124: e172–e179.

  22. Berggren A, Lazou Ahren I, Larsson N. Randomised, double-blind and placebo-controlled study using new probiotic lactobacilli for strengthening the body immune defence against viral infections. Eur J Nutr. 2010; 50: 203–210.

  23. Merenstein D, Murphy M, Fokar A. Use of a fermented dairy probiotic drink containing Lactobacillus casei (DN-114 001) to decrease the rate of illness in kids: the DRINK study. A patient-oriented, double-blind, cluster-randomized, placebo-controlled, clinical trial. Eur J Clin Nutr. 2010; 64: 669 – 677.

  24. Guillemard E, Tondu F, Lacoin F. Consumption of a fermented dairy product containing the probiotic Lactobacillus casei DN-114001 reduces the duration of respiratory infections in the elderly in a randomised controlled trial. Br J Nutr. 2010; 103: 58–68.

  25. Cox AJ, Pyne DB, Saunders PU. Oral administration of the probiotic Lactobacillus fermentum VRI-003 and mucosal immunity in endurance athletes. Br J Sports Med. 2008; 44: 222–226.

  26. Hojsak I, Snovak N, Abdovic S. Lactobacillus GG in the prevention of gastrointestinal and respiratory tract infections in children who attend day care centers: a randomized, doubleblind, placebo controlled trial. Clin Nutr. 2010; 29: 312–316.

  27. Rinne M, Kalliomaki M, Arvilommi H, Salminen S, Isolauri E. Effect of probiotics and breastfeeding on the bifidobacterium and lactobacillus/enterococcus microbiota and humoral immune responses. J Pediatr. 2005; 147: 186-191.

  28. Ogawa T, Asai Y, Tamai R, Makimura Y, Sakamoto H, Hashikawa S, et al. Natural killer cell activities of symbiotic Lactobacillus casei ssp. casei in conjunction with dextran. Clin Exp Immunol. 2006; 143:103-109.

  29. Kitazawa H, Ueha S, Itoh S, Watanabe H, Konno K, Kawai Y, et al. AT oligonucleotides inducing B lymphocyte activation exist in probiotic Lactobacillus gasseri. Int J Food Microbiol. 2001; 10(3): 149-162.

  30. Sheil B. Role of interleukin (IL-10) in probiotic mediated immune modulation: an assessment in wild-type and IL-10 knock-out mice. Clin Exp Immunol. 2006; 144: 273–280.

  31. Gill HS, Rutherfurd KJ, Cross ML, Gopal PK. Enhancement of immunity in the elderly by dietary supplementation with the probiotic Bifidobacterium lactis HN019. Am J Clin Nutr. 2001; 74(6): 833-839.

  32. Wong C. Natural treatments for eczema [Internet]. Washington: About.com Guide; c. 2001- 2013. [actualizada 13 Sep 2013; citado 2 Oct 2013] [aprox. 3 pantallas]. Disponible en: http://altmedicine.about.com/cs/conditionsetoh/a/Eczema.htm

  33. Wong C. Constipation remedies. [Internet]. Washington, USA: About.com Guide. c. 2001- 2013. [actualizada 17 Sep 2013; citado 4 Oct 2013] [aprox. 3 pantallas]. Disponible en: http://altmedicine.about.com/od/constipation/a/constipation.htm

  34. Doege K, Grajecki D, Zyriax BC, Detinkina E, Zu Eulenburg C, Buhling KJ. Impact of maternal supplementation with probiotics during pregnancy on atopic eczema in childhood--a metaanalysis. Br J Nutr. 2012; 107(1):1-6.

  35. Betsi GI, Papadavid E, Falagas ME. Probiotics for the treatment or prevention of atopic dermatitis: a review of the evidence from randomized controlled trials. Am J Clin Dermatol. 2008; 9(2):93-103.

  36. Bäckhed F, Fraser C, Ringel Y, Sanders ME, Sartor RB, Sherman PM, et al. Defining a healthy human gut microbiome: current concepts, future directions, and clinical applications. Cell Host Microbe. 2012; 12(5):611-22.

  37. Iannelli V. Natural treatments for diarrhea [Internet]. Washington: About.com Guide; c. 2002-2013 [actualizada 1 Nov 2007; citado 10 Sep 2013] [aprox. 3 pantallas]. Disponible en: http://pediatrics.about.com/od/weeklyquestion/a/05_diarrhea.htm

  38. Hickson M, D'Souza AL, Muthu N, Rogers TR, Want S, Rajkumar C, et al. Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial. Br Med J. 2007; 335:80.

  39. Lin JS, Chiu YH, Lin NT, Chu CH, Huang KC, Liao KW, et al. Different effects of probiotic species/strains on infections in preschool children: a double-blind, randomized, controlled study. Vaccine. 2009; 27:1073–1079.

  40. Agarwal KN, Bhasin SK. Feasibility studies to control acute diarrhoea in children by feeding fermented milk preparations Actimel and Indian Dahi. Eur J Clin Nutr. 2002; 56 (4):S56–S59.

  41. Marteau P, Shanahan F. Basic aspects and pharmacology of probiotics: an overview of pharmacokinetics, mechanisms of action and side-effects. Best Prac Res Clin Gastroenterol. 2003; 17: 725-740.

  42. Rijkers GT, Bengmark S, Enck P. Guidance for substantiating the evidence for beneficial effects of probio- tics: current status and recommendations for future research. J Nutr. 2010; 140: 671S–676S.

  43. Lammers KM, Vergopoulos A, Babel N, Gionchetti P, Rizzello F, Morselli C, et al. Probiotic therapy in the prevention of pouchitis onset: decreased interleukin-1beta, interleukin-8, and interferon-gamma gene expression. Inflamm Bowel Dis. 2005; 11: 447-454.




2020     |     www.medigraphic.com